• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病患儿的肾小球高滤过和肾脏进展。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2439-43. doi: 10.2215/CJN.01010211. Epub 2011 Sep 8.
2
Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.用胱抑素C估算肾小球滤过率评估常染色体显性多囊肾病早期的肾功能。
PLoS One. 2017 Mar 27;12(3):e0174583. doi: 10.1371/journal.pone.0174583. eCollection 2017.
3
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.成纤维细胞生长因子 23 与常染色体显性多囊肾病的肾脏疾病进展。
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1461-1469. doi: 10.2215/CJN.12821216. Epub 2017 Jul 13.
4
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.托伐普坦对不同肾功能水平常染色体显性多囊肾病个体的短期疗效。
Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15.
5
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病的肾脏体积和功能结局。
Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86. doi: 10.2215/CJN.09500911. Epub 2012 Feb 16.
6
Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.常染色体显性遗传多囊肾病早、晚期的肾功能储备能力。
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1680-1692. doi: 10.2215/CJN.03650318. Epub 2018 Sep 25.
7
Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.极早发型常染色体显性多囊肾病患者的长期预后
Am J Nephrol. 2016;44(3):171-8. doi: 10.1159/000448695. Epub 2016 Aug 23.
8
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.常染色体显性多囊肾病(ADPKD)早期的肾脏结构:多囊肾病放射影像学研究联盟(CRISP)队列
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
9
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.尿血管紧张素原除影像学分类外,还可预测常染色体显性遗传性多囊肾病的肾脏结局。
J Korean Med Sci. 2020 Jun 8;35(22):e165. doi: 10.3346/jkms.2020.35.e165.
10
Kidney volume and function in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中的肾脏体积与功能
Clin Exp Nephrol. 2014 Feb;18(1):157-65. doi: 10.1007/s10157-013-0834-4. Epub 2013 Jul 18.

引用本文的文献

1
Total Kidney Volume, Hypertension, and Deterioration of Kidney Function in Children with Early-Stage ADPKD.儿童早期常染色体显性多囊肾病患者的总肾体积、高血压及肾功能恶化
J Clin Med. 2025 Jun 25;14(13):4498. doi: 10.3390/jcm14134498.
2
Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances.常染色体显性多囊肾病:近期遗传学和临床进展概述
Ren Fail. 2025 Dec;47(1):2492374. doi: 10.1080/0886022X.2025.2492374. Epub 2025 Apr 23.
3
Longitudinal assessment of measured and estimated glomerular filtration-rate in autosomal dominant polycystic kidney disease: Real practice experience.常染色体显性多囊肾病中测量和估算肾小球滤过率的纵向评估:实际临床经验
World J Nephrol. 2025 Mar 25;14(1):99044. doi: 10.5527/wjn.v14.i1.99044.
4
Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial.恩格列净治疗常染色体显性遗传性多囊肾病患者(EMPA-PKD):一项随机对照试验的研究方案
BMJ Open. 2024 Dec 15;14(12):e088317. doi: 10.1136/bmjopen-2024-088317.
5
Octreotide-LAR in ADPKD patients with very low kidney function: a single-center real-life experience.奥曲肽长效释放制剂用于肾功能极低的常染色体显性多囊肾病患者:单中心真实世界经验
J Nephrol. 2024 Dec;37(9):2683-2685. doi: 10.1007/s40620-024-02145-w. Epub 2024 Nov 6.
6
Biomarkers of Kidney Disease Progression in ADPKD.常染色体显性多囊肾病中肾病进展的生物标志物
Kidney Int Rep. 2024 Jul 14;9(10):2860-2882. doi: 10.1016/j.ekir.2024.07.012. eCollection 2024 Oct.
7
Kidney Measurement and Glomerular Filtration Rate Evolution in Children with Polycystic Kidney Disease.多囊肾病患儿的肾脏测量与肾小球滤过率演变
Children (Basel). 2024 May 10;11(5):575. doi: 10.3390/children11050575.
8
Magnetic resonance imaging based kidney volume assessment for risk stratification in pediatric autosomal dominant polycystic kidney disease.基于磁共振成像的肾脏体积评估在儿童常染色体显性多囊肾病风险分层中的应用
Front Pediatr. 2024 Feb 23;12:1357365. doi: 10.3389/fped.2024.1357365. eCollection 2024.
9
Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan.评估常染色体显性遗传多囊肾病患儿疾病快速进展风险:托伐普坦的一项随机试验。
Pediatr Nephrol. 2024 May;39(5):1481-1490. doi: 10.1007/s00467-023-06239-8. Epub 2023 Dec 13.
10
Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers.预测常染色体显性多囊肾病的进展:对有前景的血清和尿液生物标志物的综述
Front Pediatr. 2023 Nov 10;11:1274435. doi: 10.3389/fped.2023.1274435. eCollection 2023.

本文引用的文献

1
Hyperfiltration affects accuracy of creatinine eGFR measurement.超滤会影响肌酐 eGFR 测量的准确性。
Clin J Am Soc Nephrol. 2011 Feb;6(2):274-80. doi: 10.2215/CJN.02760310. Epub 2010 Oct 21.
2
Comparison of plasma clearance of iohexol and urinary clearance of inulin for measurement of GFR in children.比较碘海醇的血浆清除率和菊粉的尿清除率在儿童肾小球滤过率测量中的应用。
Am J Kidney Dis. 2011 Jan;57(1):55-61. doi: 10.1053/j.ajkd.2010.07.013. Epub 2010 Sep 25.
3
Everolimus in patients with autosomal dominant polycystic kidney disease.依维莫司治疗常染色体显性遗传多囊肾病。
N Engl J Med. 2010 Aug 26;363(9):830-40. doi: 10.1056/NEJMoa1003491. Epub 2010 Jun 26.
4
Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.西罗莫司与常染色体显性多囊肾病的肾脏生长。
N Engl J Med. 2010 Aug 26;363(9):820-9. doi: 10.1056/NEJMoa0907419. Epub 2010 Jun 26.
5
The clinical significance of hyperfiltration in diabetes.糖尿病患者肾小球滤过率增高的临床意义。
Diabetologia. 2010 Oct;53(10):2093-104. doi: 10.1007/s00125-010-1794-9. Epub 2010 May 23.
6
Early renal abnormalities in autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病的早期肾脏异常。
Clin J Am Soc Nephrol. 2010 Jun;5(6):1091-8. doi: 10.2215/CJN.00360110. Epub 2010 Apr 22.
7
Autosomal dominant polycystic kidney disease: 2009 update for internists.常染色体显性多囊肾病:内科医生2009年最新资料
Korean J Intern Med. 2009 Sep;24(3):165-8. doi: 10.3904/kjim.2009.24.3.165. Epub 2009 Aug 26.
8
Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病患者的肾体积、肾素-血管紧张素-醛固酮系统、高血压及左心室肥厚
J Am Soc Nephrol. 2009 Sep;20(9):1888-93. doi: 10.1681/ASN.2008080882. Epub 2009 Aug 20.
9
Prospective change in renal volume and function in children with ADPKD.常染色体显性多囊肾病患儿肾脏体积和功能的前瞻性变化
Clin J Am Soc Nephrol. 2009 Apr;4(4):820-9. doi: 10.2215/CJN.02810608.
10
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.超滤与未来发生糖尿病肾病的风险相关吗?一项荟萃分析。
Diabetologia. 2009 Apr;52(4):691-7. doi: 10.1007/s00125-009-1268-0. Epub 2009 Feb 7.

常染色体显性遗传性多囊肾病患儿的肾小球高滤过和肾脏进展。

Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

机构信息

University of Colorado Denver, Division of Renal Diseases and Hypertension, Aurora, CO 80045, USA.

出版信息

Clin J Am Soc Nephrol. 2011 Oct;6(10):2439-43. doi: 10.2215/CJN.01010211. Epub 2011 Sep 8.

DOI:10.2215/CJN.01010211
PMID:21903987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186452/
Abstract

BACKGROUND AND OBJECTIVES

The purpose of this study was to determine whether glomerular hyperfiltration (GH) occurring early in autosomal dominant polycystic kidney disease (ADPKD) is indicative of more rapid disease progression in children.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: One hundred eighty children with ADPKD (ages 4 to 18 years) with normal renal function were examined by renal ultrasound. Renal volume was calculated using a standard formula for a modified ellipsoid. Creatinine clearance was calculated from serum creatinine and 24-hour urine creatinine. GH was defined as creatinine clearance ≥140 ml/min per 1.73 m(2).

RESULTS

Thirty-two children had GH (mean age 11.4 ± 3.6 years) and 148 had normal renal function (mean age 10.8 ± 3.9 years). Patients with GH at baseline demonstrated an increased rate of total renal volume growth (β: rate of change = +19.3 ± 10.8 cm(3)/year) over 5 years compared with those without GH at baseline (β = -4.3 ± 7.7 cm(3)/year), P = 0.008. Those with GH at baseline experienced a faster decline in creatinine clearance in subsequent years (β = -5.0 ± 0.8 ml/min per 1.73 m(2) per year) compared with those without GH at baseline (β = +1.0 ± 0.4 ml/min per 1.73 m(2) per year), P < 0.0001.

CONCLUSIONS

This study revealed that occurrence of GH in ADPKD children is associated with a significantly faster decline in renal function and higher rate of kidney enlargement over time. GH combined with the increased renal volume may therefore be used as an early marker for a more severe progression of ADPKD in children.

摘要

背景和目的

本研究旨在确定常染色体显性多囊肾病(ADPKD)早期发生的肾小球高滤过(GH)是否提示儿童患者的疾病进展更快。

设计、地点、参与者和测量方法:对 180 名肾功能正常的 ADPKD 儿童(年龄 4 至 18 岁)进行了肾脏超声检查。使用改良椭圆体的标准公式计算肾脏体积。通过血清肌酐和 24 小时尿液肌酐计算肌酐清除率。GH 的定义为肌酐清除率≥140ml/min/1.73m²。

结果

32 名儿童存在 GH(平均年龄 11.4±3.6 岁),148 名儿童肾功能正常(平均年龄 10.8±3.9 岁)。基线时存在 GH 的患者在 5 年内总肾脏体积增长率(β:变化率=+19.3±10.8cm³/年)高于基线时无 GH 的患者(β=-4.3±7.7cm³/年),P=0.008。基线时存在 GH 的患者在随后的几年中肌酐清除率下降更快(β=-5.0±0.8ml/min/1.73m²/年),而基线时无 GH 的患者则较慢(β=+1.0±0.4ml/min/1.73m²/年),P<0.0001。

结论

本研究表明,ADPKD 儿童中 GH 的发生与肾功能的显著下降以及随时间推移肾脏增大的速度加快有关。因此,GH 与增加的肾脏体积相结合,可能被用作儿童 ADPKD 更严重进展的早期标志物。